| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/18/2001 | US6331430 Motor proteins and methods for their use |
| 12/18/2001 | US6331429 Layered nutrient solution; for use in detection and propagation of bacterial cells |
| 12/18/2001 | US6331424 Motor proteins and methods for their use |
| 12/18/2001 | US6331423 Nucleotide sequences coding polypeptide for use as human therapeutic agents that modulate kinase activity |
| 12/18/2001 | US6331417 Determine amount of target nucleotide sequences in sample; mix sample with control sequences, incubate with nucleotide sequences, perform nucleotide sequence amplification, calculate amount of control and target sequences |
| 12/18/2001 | US6331411 TopA |
| 12/18/2001 | US6331407 Detecting bactericides; incubate modulator with bacterial cell and monitor killing activity of modulator |
| 12/18/2001 | US6331406 Human enbryonic germ cell and methods of use |
| 12/18/2001 | US6331405 Detection of modulators of laminin binding; incubate microorganism polypeptide with modulator, detect bound complex, the absence of binding to laminin receptor indicates bound complex |
| 12/18/2001 | US6331398 Nucleic acid ligands |
| 12/18/2001 | US6331396 Layout for detecting modulators of cytokine activity; for use in diagnosis and prevention of viral infection, leukemia and multiple sclerosis |
| 12/18/2001 | US6331394 Contacting candidate mixture of nucleic acids with integrin, wherein nucleic acids having increased affinity to integrin relative to candidate mixture may be partitioned from remainder of mixture, partitioning, amplififying |
| 12/18/2001 | US6331393 Detecting cytosine methylation and methylated cytosine/guanine aggregations; incubate genomic nucleotide sequences adjusting agent, amplify nucleotide sequences, detecting the methylated nucleotide sequences |
| 12/18/2001 | US6331392 Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids |
| 12/18/2001 | US6331390 Cell-cycle regulatory proteins, and uses related thereto |
| 12/18/2001 | US6331389 Determining sensitivity of viricides; hybridize nucleotide sequences, detect hybrids, determine nucleotide sequences from hybridization signal, classify viral sequences |
| 12/18/2001 | US6331356 Polyparaphenylene vinylenes, polyparaphenylenes, polyanilines, polythiophenes, polyazines, polyfuranes, polypyrroles, polyselenophenes, poly-p-phenylene sulfides, polyacetylenes, and blends |
| 12/18/2001 | US6331302 Protein tyrosine kinase agonist antibodies |
| 12/18/2001 | US6331275 Spatially addressable, cleavable reflective signal elements, assay device and method |
| 12/18/2001 | US6331274 Advanced active circuits and devices for molecular biological analysis and diagnostics |
| 12/18/2001 | CA2179281C Methods of identifying lymphocytes with mutator phenotypes |
| 12/18/2001 | CA2134478C Microfabricated detection structures |
| 12/18/2001 | CA2125004C Simultaneous amplification of multiple targets |
| 12/18/2001 | CA2088661C Glyphosate tolerant 5-enolpyruvylshikimate-3-phosphate synthases |
| 12/18/2001 | CA2067394C Enzyme amplified lanthanide chelate luminescence assay |
| 12/18/2001 | CA2045839C Cloned n-methylhydantoinase |
| 12/16/2001 | CA2350976A1 Cell libraries indexed to nucleic acid microarrays |
| 12/13/2001 | WO2001095233A2 Analysis of data from liquid chromatographic separation of dna |
| 12/13/2001 | WO2001094952A2 Methods and compositions for modulating oxidized ldl transport |
| 12/13/2001 | WO2001094951A2 Inhibitors of c-reactive protein induced inflammation |
| 12/13/2001 | WO2001094946A2 Microarrays for performing proteomic analyses |
| 12/13/2001 | WO2001094940A1 Method for histocompatibility testing |
| 12/13/2001 | WO2001094924A2 Method for analysing enzyme-catalysed reactions using maldi-tof mass spectrometry |
| 12/13/2001 | WO2001094645A1 Two-hybrid assay that detects hiv-1 reverse transcriptase dimerization |
| 12/13/2001 | WO2001094644A1 Method for detecting and/or quantifying minority variants within a heterogeneous viral population in a biological sample |
| 12/13/2001 | WO2001094643A2 Powdery mildew resistant plants |
| 12/13/2001 | WO2001094642A2 Association of mhc class ii alleles and cancer |
| 12/13/2001 | WO2001094641A2 Gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas |
| 12/13/2001 | WO2001094639A1 Address/capture tags for flow-cytometry based minisequencing |
| 12/13/2001 | WO2001094638A2 Asynchronous primed pcr |
| 12/13/2001 | WO2001094637A1 Haplotypes of the naga gene |
| 12/13/2001 | WO2001094636A2 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 12/13/2001 | WO2001094635A2 Integrated active flux microfluidic devices and methods |
| 12/13/2001 | WO2001094634A2 Methods and devices for multiplexing amplification reactions |
| 12/13/2001 | WO2001094633A1 Genetic typing of the human cytochrome p450 2a6 gene and related materials and methods |
| 12/13/2001 | WO2001094632A2 Highly sensitive gene detection and localization using in situ branched-dna hybridization |
| 12/13/2001 | WO2001094631A1 Methods for detection of cryptosporidium species and isolates and for diagnosis of cryptosporidiuminfections |
| 12/13/2001 | WO2001094630A2 Compositions and methods for array-based nucleic acid hybridization |
| 12/13/2001 | WO2001094629A2 Cancer gene determination and therapeutic screening using signature gene sets |
| 12/13/2001 | WO2001094628A1 Sequencing method with three primers |
| 12/13/2001 | WO2001094627A2 Assay techniques based on growth stage dependent expression in c. elegans |
| 12/13/2001 | WO2001094626A1 Polynucleotides |
| 12/13/2001 | WO2001094625A2 Capture moieties for nucleic acids and uses thereof |
| 12/13/2001 | WO2001094624A1 Method to detect modulators of vegf kinase domain |
| 12/13/2001 | WO2001094623A1 Assay for detection of translocase enzyme activity in drug screening |
| 12/13/2001 | WO2001094622A1 Assay for detection of transferase enzyme activity in drug screening |
| 12/13/2001 | WO2001094621A1 Screening method for modulators of suv39h2-methyltransferase |
| 12/13/2001 | WO2001094620A1 Screening-method for modulators of methyltransferase-dependent chromosome stability |
| 12/13/2001 | WO2001094619A1 Method of analyzing components in biological samples |
| 12/13/2001 | WO2001094617A2 Protein fragment complementation assay based on beta-lactamase |
| 12/13/2001 | WO2001094616A1 Protein markers for pharmaceuticals and related toxicity |
| 12/13/2001 | WO2001094615A2 Method for breeding and genotyping chickens and probes therefor |
| 12/13/2001 | WO2001094614A2 Methods for monitoring enzyme activity |
| 12/13/2001 | WO2001094612A2 Method for identifying medically valuable active substances |
| 12/13/2001 | WO2001094611A2 Method and system for predicting nucleic acid hybridization thermodynamics and computer-readable storage medium for use therein |
| 12/13/2001 | WO2001094609A1 Charge-switch nucleotides |
| 12/13/2001 | WO2001094600A2 Promoters for regulated gene expression |
| 12/13/2001 | WO2001094587A2 Extracellular messengers |
| 12/13/2001 | WO2001094584A2 21784, a novel human calcium channel family member and uses thereof |
| 12/13/2001 | WO2001094581A1 Tumour suppressor and uses thereof |
| 12/13/2001 | WO2001094562A2 Cold sensitive mutant dna polymerases |
| 12/13/2001 | WO2001094559A1 Hepatitis b virus dna polymerase and surface antigen variants and methods of using same |
| 12/13/2001 | WO2001094557A1 Human chemokine beta-10 mutant polypeptides |
| 12/13/2001 | WO2001094550A2 Identification and use of molecular markers indicating cellular reprogramming |
| 12/13/2001 | WO2001094548A2 Hy2 family of bilin reductases |
| 12/13/2001 | WO2001094546A2 Primer extension using a mixture of labelled and unlabelled nucleotides |
| 12/13/2001 | WO2001094542A2 Algorithmic determination of connectrons |
| 12/13/2001 | WO2001094541A2 Human mesenchymal progenitor cell |
| 12/13/2001 | WO2001094528A2 Visual-servoing optical microscopy |
| 12/13/2001 | WO2001094527A2 Preparing a sample to be analysed from a sample with very large volume |
| 12/13/2001 | WO2001094420A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 12/13/2001 | WO2001094415A2 Nuclear hormone receptor |
| 12/13/2001 | WO2001094413A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | WO2001094408A1 Tyrosine kinase modulators |
| 12/13/2001 | WO2001094391A2 Intracellular signaling proteins |
| 12/13/2001 | WO2001094380A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/13/2001 | WO2001094376A1 Haplotypes of the cfl1 gene |
| 12/13/2001 | WO2001094370A1 Coenzyme derivatives and enzymes appropriate therefor |
| 12/13/2001 | WO2001094365A2 Haplotypes of the phkg2 gene |
| 12/13/2001 | WO2001094364A2 Haplotypes of the csf3 gene |
| 12/13/2001 | WO2001094363A2 Haplotypes of the pfkfb2 gene |
| 12/13/2001 | WO2001094362A2 Haplotypes of the acp2 gene |
| 12/13/2001 | WO2001094361A2 Haplotypes of the pcdh2 gene |
| 12/13/2001 | WO2001094332A1 Profiling of protease specificity using combinatorial fluorogenic substrate libraries |
| 12/13/2001 | WO2001093983A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | WO2001093851A2 Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3 |
| 12/13/2001 | WO2001093669A2 Compound screens relating to insulin deficiency or insulin resistance |
| 12/13/2001 | WO2001072772A3 Calcium binding regulatory subunit |
| 12/13/2001 | WO2001055325A8 Nucleic acids, proteins, and antibodies |
| 12/13/2001 | WO2001055206A8 Nucleic acids, proteins, and antibodies |